Navigation Links
Bend Research Named Large Distinguished Business of the Year by Bend Chamber of Commerce Membership

BEND, Ore., June 29, 2011 /PRNewswire-USNewswire/ -- Bend Research Inc. (, a leading independent drug-formulation development and manufacturing company, has been named Large Distinguished Business of the Year by the Bend Chamber of Commerce membership.

The award was announced at the Chamber's annual SAGE Awards banquet in late May.

According to the Bend Chamber, the annual award recognizes the large business among the Bend Chamber membership that has "…a reputation for providing outstanding products and/or services to their customers."

The Chamber noted that Bend Research is a "…cornerstone of Central Oregon's high-tech industry, taking pride in improving human health through innovation as well as contributing to the next generation of scientists."

"We're very honored to receive this award from the Chamber," said Rod Ray, president and chief executive officer of Bend Research Inc. "Our Central Oregon roots are a big part of what this company is all about, so this recognition means a lot to us."

The SAGE Awards is a competitive process. Businesses are nominated and then voted on by the Bend Chamber membership. Other nominees in the large business category were Eberhard's Dairy Products, family-owned and operated since 1951; and Tomco Electric Inc., established in 1973.

The Bend Chamber is one of the largest and most active chambers in Oregon, representing 1,200 businesses with more than 23,000 employees. In addition to acknowledging a distinguished large business, the chamber also recognized Donner Flowers as the Small Distinguished Business of the Year; Saving Grace as the Outstanding Organization of the Year; and Oran Teater, business leader and former mayor of Bend, as Citizen of the Year.

About Bend Research Inc.

For more than 30 years, Bend Research has worked with clients to create value by advancing new medicines that improve human health and to solve their most difficult scientific and technical problems. This success is based on the company's ability to develop, advance, and commercialize pharmaceutical technologies. The firm's innovative drug-delivery solutions grow from a solid base of scientific and engineering fundamental understanding.

Bend Research provides formulation and dosage-form support, assists in process development and optimization, manufactures clinical-trial quantities of drug candidates in its cGMP facilities, and advances promising drug candidates from conception through commercialization. Bend Research is a leader in novel formulations, including solubilization technologies such as spray-dried dispersions and hot-melt extrusion formulations, as well as controlled-release, inhalation, and biotherapeutics technologies.

Bend Research has more than 200 employees based in four state-of-the-art facilities in Bend, Oregon, USA. For more information about Bend Research and the SAGE award, please contact Phoenix Ivers via email at or phone at 541-382-4100.

SOURCE Bend Research Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. Napoleone Ferrara Wins 2011 Dr. Paul Janssen Award for Biomedical Research
2. Advocates, 150 Children With Type 1 Diabetes Urge FDA to Enable Critical Research on Life-Saving Artificial Pancreas to Move Forward
3. Cepheid Appoints Vice President of Infectious Disease Research & Development
4. Study Identifies Large Concentration of Contract Research Assets in Kansas City Region
5. AlphaDetail, Healthcare Market Research Specialist, Named to the Honomichl Top 50
6. Research Finds Greater Focus on Self-Care Would Save Patients and U.S. Healthcare System Over $5 Billion Annually
7. Research Led by Clinical Nurse Specialists Reconfirms Reliability of Temporal Artery Thermometry
8. Sanofi Enters Into Research Collaboration With Biopharmaceutical Company Audion Therapeutics to Develop Potential Treatments for Hearing Loss
9. ViaCyte Names Michael Scott Vice President, Device Research & Development
10. Research 2.0 Updates Coverage of Viral Genetics with Research Report Focused on VG Energy
11. Best of ASCO Features Two Studies Led by US Oncology Research Affiliated Physicians
Post Your Comments:
(Date:11/26/2015)... 2015 ) ... "Radioimmunoassay Market by Type (Reagents & Kits, ... Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), ... report to their offering. --> ... of the "Radioimmunoassay Market by Type ...
(Date:11/25/2015)... 2015 ... "Global Brain Monitoring Devices Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
Breaking Medicine Technology:
(Date:11/29/2015)... ... ... Effective immediately, every single IguanaMed scrub style will be available at Target via ... “Buy One Scrub Set, Get the 2nd Scrub Set 50% Off” for a limited ... price. , IguanaMed’s mission is to outfit every healer around the world ...
(Date:11/28/2015)... , ... November 28, 2015 , ... Safe storage for ... of two inventors, one from Lakewood, New Jersey and the other from Bradley Beach, ... patent-pending PROTECTOR to save the expense of having to replace NuvaRings more often than ...
(Date:11/28/2015)... ... November 28, 2015 , ... Pixel Film Studios is back again ... choose from, the possibilities are endless. Users have full control over angle of view, ... masking effects, users are sure to get heads to turn. , ProPanel: Pulse offers ...
(Date:11/27/2015)... ... 27, 2015 , ... According to an article published November 6th ... the University of British Columbia suggested that laws requiring bicyclists to wear helmets may ... part of the reason for the controversial conclusion is that, while helmets have certainly ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A team of ... ways to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy ...
Breaking Medicine News(10 mins):